S. Lenzen et T. Peckmann, Effects of tolbutamide and N-benzoyl-D-phenylalanine (NBDP) on the regulation of [Ca2+](i) oscillations in mouse pancreatic islets, BIOCH PHARM, 62(7), 2001, pp. 923-928
The sulfonylurea. derivative, tolbutamide, and the phenylalanine derivative
, N-benzoyl-D-phenylalanine (NBDP), both of which stimulate insulin secreti
on through interaction with the sulfonylurea receptor (SUR1), were studied
for their ability to increase the [Ca2+](i) and to interact with the glucos
e-induced slow large amplitude [Ca2+](i) oscillations in isolated mouse pan
creatic islets. Tolbutamide as wen as NBDP induced [Ca2+](i) oscillations o
f extremely slow frequency. Both compounds also lowered the threshold for t
he glucose-induced slow large amplitude [Ca2+], oscillations and significan
tly reduced their frequency in intact islets as well as in single pancreati
c beta cells. These [Ca2+](i) oscillations apparently require a glucokinase
-mediated glycolytic flux. This conclusion is supported by the observations
that KIC, a mitochondrial fuel, cannot replace glucose in this synergism a
nd that mannoheptulose, an inhibitor of glucokinase and glucose-induced ins
ulin secretion, abolishes these slow [Ca2+](i) oscillations. In conclusion,
these compounds potentiate the effect of glucose. This additive effect is
the likely result of a synergistic closing action upon the ATP-sensitive K (K-ATP) channel, mediated in the case of glucose through an action upon th
e channel protein itself of ATP generated in glucose catabolism and in the
case of tolbutamide. and NBDP upon the sulfonylurea receptor (SUR1) associa
ted with this channel. (C) 2001 Elsevier Science Inc. All rights reserved.